经济观察网中欣氟材（002915）2025年业绩预告显示扭亏为盈，同时公司向特定对象发行股票的申请已 获证监会批复。 公司计划募集资金1.86亿元，用于扩建"年产2000吨BPEF、500吨BPF及1000吨9-芴酮"等项目，以加强 新材料领域布局。发行价格为18.97元/股，项目终端应用涵盖汽车、电子、航空航天等领域。 近期事件 2026年2月4日，公司收到中国证监会出具的同意向特定对象发行股票注册的批复，标志着该融资计划进 入实施阶段。 以上内容基于公开资料整理，不构成投资建议。 业绩经营情况 公司于2026年1月29日发布2025年度业绩预告，预计全年归属于上市公司股东的净利润为1600万元至 2000万元，同比实现扭亏为盈；扣非后净利润为450万元至675万元。业绩改善主要受益于农药中间体需 求回暖、子公司福建高宝减亏及营收双位数增长。 定增股票 ...

证券日报网讯 2月12日，中欣氟材在互动平台回答投资者提问时表示，截至2026年2月10日公司股东人 数为61435户。 （文章来源：证券日报） ...

证券代码：002915 证券简称：中欣氟材 公告编号：2026-006 浙江中欣氟材股份有限公司 关于控股子公司、全资孙公司变更法定代表人 （一）江西埃克盛换发的《营业执照》 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 公司名称：江西中欣埃克盛新材料有限公司 浙江中欣氟材股份有限公司（以下简称"公司"）于近日收到控股子公司江 西中欣埃克盛新材料有限公司（以下简称"江西埃克盛"）、全资孙公司明溪县 长兴萤石矿业有限公司（以下简称"长兴萤石"）的通知，因战略规划和经营发 展需要，江西埃克盛、长兴萤石对其法定代表人进行了变更，现已完成工商变更 登记手续，并分别取得了贵溪市行政审批局及明溪县市场监督管理局换发的《营 业执照》。具体情况如下： 一、本次变更登记的具体内容 （一）江西埃克盛本次变更登记的具体内容 | 变更事项 | 变更前 | 变更后 | | --- | --- | --- | | 法定代表人 | 徐寅子 | 袁少岚 | （二）长兴萤石本次变更登记的具体内容 | 变更事项 | 变更前 | 变更后 | | --- | --- | --- | | 法定代表人 ...

Industry Overview - The fluorochemical industry is experiencing a significant increase in demand driven by emerging sectors such as new energy, high-end electronics, semiconductors, and energy storage [1][2] - Domestic fluorochemical companies are accelerating capacity expansion and industrial upgrades, with plans to implement these expansions by 2026 [1] Company Developments - Zhejiang Zhongxin Fluorine Materials Co., Ltd. has received approval for a 186 million yuan private placement to fund projects including the production of 2,000 tons of BPEF, 500 tons of BPF, and 1,000 tons of 9-fluorenone, along with working capital [1] - Haohua Chemical Technology Group Co., Ltd. plans to invest 3.347 billion yuan in projects including a 26,000 tons/year high-performance organic fluorine materials project and a 4,000 tons/year fluorine fine chemicals project, with the latter expected to be completed by November this year [1] Market Trends - The expansion of fluorochemical companies is characterized by a focus on environmentally friendly refrigerants, high fluoropolymer materials, and fine chemicals, aligning with global low-carbon trends [2] - The industry is moving towards integration of upstream and downstream operations to enhance self-sufficiency in the supply chain [2] Policy Alignment - The industry's growth aligns with national policy directives aimed at promoting innovation in fine chemicals and improving the quality of bulk products through smart, green, and safe transformations [3] - Regulatory measures are being implemented to accelerate the green transition in the industry, including quota management for hydrofluorocarbon production [3] Future Outlook - Experts indicate that the domestic fluorochemical industry is at a critical juncture, transitioning from scale expansion to quality enhancement [3] - Despite challenges such as raw material price fluctuations and intense competition among leading companies, there are multiple development opportunities driven by supportive policies and continuous demand growth [3]

Core Viewpoint - The company announced the approval of using up to 100 million yuan of idle self-owned funds for financial management, with a usage period of 12 months [1] Group 1: Financial Management - The company’s board approved the use of idle funds for financial management, indicating a proactive approach to optimize asset utilization [1] - A subsidiary, Jiangxi Aikesen, redeemed a structured deposit product from China Merchants Bank, with a principal amount of 60 million yuan and received an actual return of 335,638.36 yuan [1] - Over the past 12 months, Jiangxi Aikesen has repeatedly purchased similar financial products, all of which have been redeemed with profits [1]

近日，公司使用闲置自有资金进行现金管理的产品到期赎回并继续进行现金 管理，现就相关情况公告如下： 一、使用闲置自有资金进行现金管理到期赎回的基本情况 公司子公司江西中欣埃克盛新材料有限公司（以下简称"江西埃克盛"）与招 商银行股份有限公司绍兴分行营业部签订协议，使用闲置自有资金进行现金管理， 具体内容详见公司于 2025 年 10 月 10 日在巨潮资讯网（http://www.cninfo.com.cn） 上披露的《关于使用闲置自有资金进行现金管理到期赎回并继续进行现金管理的 公告》（公告编号：2025-074）。公司已赎回本金 6,000 万元并收到理财收益 335,638.36 元，具体情况如下： | 购买 | 受托方 | 产品 | 产品 | 金额 | 起息日 | 到期日 | 预计年化 | 实际收益 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 主体 | 名称 | 类型 | 名称 | （万元） | | | 收益率 | （元） | 证券代码：002915 证券简称：中欣氟材 公告编号：2026-005 浙江中欣氟材股份有限公司 关于 ...

Core Viewpoint - Zhejiang Zhongxin Fluorine Materials Co., Ltd. has received approval from the CSRC for a simplified procedure to issue shares to specific targets, raising a total of 186 million yuan for projects related to new materials and working capital [1] Group 1: Company Developments - The funds raised will be used for the construction of projects to produce 2000 tons of BPEF, 500 tons of BPF, and 1000 tons of 9-fluorenone, which are essential for the company's main business in the new materials sector [1] - The implementation of these projects is expected to enhance the company's core business advantages, expand product offerings, and strengthen its industry influence and profitability [1] Group 2: Industry Context - The new materials industry is a strategic and foundational sector that supports the modern industrial system and is crucial for developing new production capabilities and growth drivers [1] - The Chinese government has been actively promoting the development of the new materials industry through various supportive policies, leading to rapid growth and expansion of the market [1] Group 3: Market Opportunities - BPEF and BPF products are widely used in the synthesis of high polymer materials, with demand spanning high-growth sectors such as automotive, electronics, optical devices, smart home, aerospace, and defense [2] - The current market for BPEF shows a significant supply gap due to the limited number of domestic commercial production enterprises, providing a market opportunity for Zhongxin Fluorine Materials to expand production [2] Group 4: Strategic Insights - The production of 9-fluorenone as a core intermediate will effectively reduce the procurement costs and supply risks for BPEF and BPF, giving the company a competitive edge through vertical integration [3] - The combination of BPEF and BPF products will allow the company to meet diverse market demands, further solidifying its leading position in the BPEF market [3]

Group 1 - The PEEK concept sector is showing strength, with notable stock increases from companies such as Zhaomin Technology, Xingrui Technology, Xinhan New Materials, Zhongxin Fluorine Materials, Henghe Precision, and Kent Shares [1] - The stocks mentioned are leading in terms of percentage gains within the PEEK concept sector [1] - The report indicates a significant market movement in the PEEK sector as of February 6, with specific companies highlighted for their performance [1]

Core Viewpoint - Zhejiang Zhongxin Fluorine Materials Co., Ltd. has received approval from the China Securities Regulatory Commission for a simplified procedure to issue stocks to specific investors for the year 2025 [1][2]. Group 1 - The company has been granted registration approval for the stock issuance application [1]. - The issuance must be conducted strictly according to the submitted documents and issuance plan to the Shenzhen Stock Exchange [2]. - The company is required to complete the issuance payment within ten working days from the date of the approval [3]. Group 2 - The company must report any significant events to the Shenzhen Stock Exchange from the date of approval until the completion of the issuance [3]. - The board of directors will handle the stock issuance matters within the stipulated timeframe and fulfill information disclosure obligations [3]. - Contact information for the issuer and the sponsor institution (main underwriter) is provided for further inquiries [4].

Group 1 - Company Jianhui Information plans to acquire 38% equity in Boke Guoxin for RMB 73.71 million, increasing its stake from 32% to 70%, making Boke Guoxin a subsidiary [1] - Company Guangshengtang's innovative drug GST-HG141 for hepatitis B has completed the enrollment of 578 participants in its Phase III clinical trial [2] - Company Hongjing Optoelectronics is establishing a partnership with a target scale of RMB 290 million, contributing RMB 3 million as a limited partner [3] Group 2 - Company Hongchang Technology intends to acquire 21% equity in Liangzhi Joint, which will make it the controlling shareholder with a 51% stake [4] - Company Xiexin Integrated has not yet received any orders in the "space photovoltaic" sector, which remains in the exploratory phase [5] - Company Xianheng International plans to reduce its shareholding by up to 3%, amounting to a maximum of 12.28 million shares [6] Group 3 - Company Furuijia plans to reduce its repurchased shares by up to 2%, totaling 18.93 million shares [7] - Company Tianqimo is planning to issue shares and pay cash to acquire assets, leading to a temporary suspension of its stock [8] - Company Shuangqiang Technology's director plans to reduce his holdings by up to 0.32% [9] Group 4 - Company Bairun plans to adjust the conversion price of its bonds due to stock prices falling below 85% of the conversion price [11] - Company Dongnan Network has won an EPC project worth RMB 994 million [12] - Company Anhui Energy has appointed Xu Wengong as the new general manager following the resignation of Fang Shiqing [13] Group 5 - Company Lijun plans to invest up to USD 3 million to establish subsidiaries in Hong Kong and Peru [14] - Company Zhenghe Ecology has signed a strategic cooperation agreement with the government of Beijing's Miyun District [15] - Company First Venture has elected Guo Chuan as the chairman of its board [16] Group 6 - Company Changxin Bochuang's shareholder has terminated an agreement to transfer 14.5 million shares [17] - Company Hengrui Medicine's HR091506 tablet application has been accepted by the National Medical Products Administration [18] - Company Hengrui Medicine's SHR-1894 injection has received approval for clinical trials [20] Group 7 - Company Longshen Rongfa has obtained a medical device production license [21] - Company Western Securities reported that its new borrowings exceeded 20% of its net assets [22] - Company Rongfa Nuclear Power's subsidiary has won a project worth RMB 101 million [23] Group 8 - Company Taiji Industry's subsidiary has a pre-bid for the Huahong FAB9B project with a bid amount of RMB 3.778 billion [24] - Company Suzhou High-tech plans to increase its investment in a subsidiary by RMB 780 million through a debt-to-equity swap [26] - Company Electric Power Investment's vice president has resigned due to work changes [27] Group 9 - Company Hengwei Technology reported a 30.13% increase in net profit for 2025 [28] - Company Fangsheng Pharmaceutical's subsidiary has received a drug production license [29] - Company Pilin Bio's subsidiary has received a notice for clinical trial acceptance for a hemostatic drug [31] Group 10 - Company Zhongxin Fluorine Material has received approval for a stock issuance to specific investors [32] - Company Shanhe Intelligent expects a total transaction amount with related parties to be RMB 1.197 billion in 2026 [33] - Company Warner Pharmaceutical's partner has completed Phase I clinical trials for a new drug [34]